Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey.
2014
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Hacettepe University, Ankara, Turkey.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Review of H1 antihistamines in the treatment of chronic idiopathic urticaria.
August 2005, Cutis,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
H1-Antihistamines May No Longer Be Necessary for Patients With Refractory Chronic Spontaneous Urticaria After Initiation of Omalizumab.
April 2020, Journal of investigational allergology & clinical immunology,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Nonsedating H1 antihistamines in chronic urticaria.
December 1993, Annals of allergy,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Cost-effectiveness of H1-antihistamines.
January 2002, Clinical allergy and immunology,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
[Treatment of chronic urticaria resistant to H1 antihistamines].
May 2003, Annales de dermatologie et de venereologie,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Recalcitrant chronic urticaria treated with dupilumab: Report of two instances refractory to H1-antihistamines, omalizumab and cyclosporine and brief literature review.
March 2021, Dermatologic therapy,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
H1-antihistamines for chronic spontaneous urticaria.
November 2014, The Cochrane database of systematic reviews,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Treating chronic urticaria refractory to H1-antihistamines in Russia: data from the AWARE study.
June 2022, Postepy dermatologii i alergologii,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Effective treatment of different H1-antihistamine-refractory chronic urticaria phenotypes with omalizumab.
December 2018, Turk pediatri arsivi,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment.
January 2021, Dermatologic therapy,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name